Estimating the burden of malignant neoplasm in Shandong Province

Jiandong Sun(Queensland University of Technology), Wěi Li(Shougang (China)), Weika Li, Jiyu Zhang(Shanghai Jiao Tong University), Tao Wang, Zhentao Fu(Shandong Center for Disease Control and Prevention), Zilong Lu(Sun Yat-sen University), Xiaolei Guo(Shandong Center for Disease Control and Prevention), Aiqiang Xu(Shandong University)
Zhongguo weisheng jingji
January 1, 2007
Cited by 2

Related Papers

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|The Lancet|2022|664
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416